Page results
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the testes.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
-
From 10 September 2025, proxies will be able to see more information in your MyCare account. Proxies are individuals such as parents or carers who have access to your MyCare account.
-
This page has been written for patients who are having radiotherapy or proton beam therapy to the oesophagus.
-
General urology is now reopen to GP referrals. Should you wish to refer to LUTS or benign prostate services at UCLH, you can do so via the e-referrals service.
-
Contact the Patient Advice and Liaison Service (PALS)
-
GP queries and contact form
-
Communication to clinicians using the biochemistry laboratory service provided by HSL. From 14 April 2025 zinc analyses on blood samples will be changed to state of the art Inductively Coupled Mass Spectrometry (ICP-MS).
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
File results
-
FOI/2024/0372 - Contact details of e-learning department
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine